A Guernsey family has been forced to sell some of their belongings to pay for their baby's essential medication. The family's struggle highlights a critical issue: the high cost of medication not funded by the States of Guernsey. The nine-month-old, Arnold, suffers from dysmotility and hypermotility, a disorder affecting his digestive system. His medication, Mebeverine, is not covered by the States of Guernsey, leaving the family with a hefty monthly bill of £312.70 per bottle. This is a significant burden for any family, especially one with four children. The family has been advised to reduce Arnold's dosage, but this has made his condition worse. They are now at a loss, unsure of where to turn for help. The Chief Pharmacist, Teena Bhogal, acknowledges the issue and encourages clinicians to reach out for advice. However, the family feels let down by the system, questioning why medication for a chronic illness should be so expensive. This story raises important questions about healthcare accessibility and the impact of medication costs on families. It's a reminder that we must ensure that essential medications are affordable and accessible to all, regardless of their financial situation.
